Translational Cancer Research on Urogenital Malignancies

Pfizer IIS Grant for Anti-Metastasis Drugs

I’m pleased to announce that Pfizer Canada will be awarding us a special IIS grant to develop anti-metastasis therapies for prostate cancer and breast cancer. Metastasis is a very difficult cancer to treat because there can be many of them and inaccessible to treatment. This grant is a real shot in the arm for us and will pay dividends as we move forward with industry partners to combat metastasis.